licensing agreement
Sino Biopharmaceutical Enters Exclusive Global Licensing Agreement with Sanofi for First-in-Class JAK/ROCK Inhibitor Rovadicitinib
2026-03-04
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
LATEST
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan







